Biologics

Innovent Announces An Agreement with Synaffix

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medi...

 June 29, 2021 | News

Waters to Help Accelerate Biologics Production Through Research Collaboration With SBTI

Waters expands collaboration with Bioprocessing Technology Institute, A*STAR into new areas meant to accelerate bioprocessing and bioinformatics research...

 June 28, 2021 | News

Nucleai and Merck Launch Translational Medicine Collaboration

Nucleai (www.nucleaimd.com), a precision medicine company using AI-powered image analysis technology to support novel pathology-based biomarker development...

 June 25, 2021 | News

Duke-NUS and GenScript notice of allowance for U.S. patent application for SARS-CoV-2 surrogate virus neutralisation test

Developed by Professor Linfa Wang and his team from Duke-NUS, the sVNT neutralization antibody detection technology is exclusively licensed to Ge...

 June 25, 2021 | News

China's first CAR-T Cell Therapy (FKC876) approved

The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy in China Individualized living-cell-based medicine: genetica...

 June 24, 2021 | News

Merck Receives Patent for Improved CRISPR Genome-Editing Method in Japan

Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions ...

 June 23, 2021 | News

eTheRNA and VUB expand strategic collaboration to engineer next generation mRNA therapeutics with TetraMix®

eTheRNA immunotherapies NV  a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, announ...

 June 23, 2021 | News

Innovent Biologics Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medi...

 June 22, 2021 | News

MSD Announces Supply Agreement with U.S. Govt. for Molnupiravir

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it has entered into a procurement agreement with&...

 June 21, 2021 | News

CARsgen Therapeutics officially listing on HKEX

CARsgen Therapeutics Holdings Limited (the "Company", stock code: 2171.HK) today announced that the Company's Shares have been traded on the Main Board of ...

 June 19, 2021 | News

Totient, a Viva Biotech Portfolio Company, has been Acquired by AbSci

Viva Biotech (01873.HK) declared today that Totient, one of its portfolio companies, has been acquired by AbSci, a synthetic biology company unlocking the ...

 June 16, 2021 | News

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy

93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against...

 June 15, 2021 | News

Chinese biotech firm Vazyme to showcase full range of COVID-19 Testing Solutions at Medlab

Medlab has become a world-famous laboratory exhibition and a globally-recognized professional IVD expo with international stature. Last year alone, the eve...

 June 15, 2021 | News

VERAXA Biotech and Quadira Biosciences Enter Partnership on ADC Development

The collaboration will leverage both the advantages of VERAXA's advanced and proprietary position-true click-chemistry-based drug conjugation technology in...

 June 14, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close